Sign in

CIK 0001862150

  • Emerging growth company

Cingulate Inc.

Sign in to watch
Ticker
CING
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
863825535
Phone
+1 913-942-2300
Business address
1901 W. 47TH PLACE, KANSAS CITY, KS, 66205
Former names
Cingulate Inc.

Securities

  • CING Common Stock Nasdaq
  • CINGW Warrants Nasdaq
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market buy Chief Executive Officer bought 10,000 shares at $1.02 ($10,166)
  5. 4 Open-market buy Director bought 28,934 shares at $0.98 ($28,422)
  6. 4 Open-market buy Chief Executive Officer bought 15,000 shares at $1.01 ($15,150)
  7. 4 Open-market buy Corporate Controller bought 7,548 shares at $0.99 ($7,468)
  8. 4 Open-market buy EVP and COO bought 1,111 shares at $0.90 ($1,000)
  9. 4 Open-market buy Corporate Controller bought 5,017 shares at an average $0.98 ($4,916)
  10. 4 Open-market buy EVP, GC and Secretary bought 3,575 shares at $0.84 ($3,003)
  11. 4 Open-market buy Director bought 85,000 shares at $0.88 ($74,851)
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market sale Director sold 17,532 shares at $1.27 ($22,208)
  14. 4 Open-market buy Corporate Controller bought 3,500 shares at $1.50 ($5,250)
  15. 4 Open-market buy Director bought 74,500 shares at $1.52 ($113,225)
  16. 4 Open-market buy EVP and COO bought 636 shares at $1.57 ($999)
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 4 Derivatives Options or other derivatives
  20. 4 Open-market buy EVP and COO bought 200 shares at $1.18 ($236)

Page 6 of 9 · 175 filings